Self-Collected Specimens Revealed a Higher Vaccine- and Non-Vaccine-Type Human Papillomavirus Prevalences in a Cross-Sectional Study in Akuse
Table 3
HPV genotype prevalence determined with each type of specimen.
HPV genotype
Self-collected specimens,
Provider-collected specimens,
Total infections
Multiple infection
Prevalence
95% CI∗
Total infections
Multiple infection
Prevalence
95% CI∗
HPV16b, q, n
15
9
5.9
3.0–9.0
6
1
2.4
1.0–5.0
HPV35
12
9
4.7
2.0–8.0
7
2
2.8
1.0–5.0
HPV40
12
9
4.7
2.0–8.0
4
4
1.6
0.0–4.0
HPV45n
11
7
4.3
2.0–7.0
5
2
2.0
0.0–4.0
HPV58n
10
5
4.0
2.0–7.0
7
1
2.8
1.0–5.0
HPV18b, q, n
9
7
3.6
1.0–6.0
6
1
2.4
1.0–5.0
HPV66
8
5
3.2
1.0–6.0
6
6
2.4
1.0–5.0
HPV59
7
5
2.8
1.0–5.0
3
2
1.2
0.0–3.0
HPV6q, n
7
4
2.8
1.0–5.0
3
0
1.2
0.0–3.0
HPV31n
7
2
2.8
1.0–5.0
2
0
0.8
0.0–2.0
HPV74
7
2
2.8
1.0–5.0
1
0
0.4
0.0–1.0
HPV42
5
3
2.0
0.0–4.0
5
4
2.0
0.0–4.0
HPV52n
5
3
2.0
0.0–4.0
4
2
1.6
0.0–4.0
HPV51
5
4
2.0
0.0–4.0
3
3
1.2
0.0–3.0
HPV62
5
3
2.0
0.0–4.0
2
1
0.8
0.0–2.0
HPV81
5
3
2.0
0.0–4.0
1
1
0.4
0.0–1.0
HPV83
5
4
2.0
0.0–4.0
1
0
0.4
0.0–1.0
HPV72
5
5
2.0
0.0–4.0
ND
ND
ND
HPV90
5
4
2.0
0.0–4.0
ND
ND
ND
HPV67
4
2
1.6
0.0–3.0
1
1
0.4
0.0–1.0
HPV53
4
2
1.6
0.0–3.0
ND
ND
ND
HPV56
3
3
1.2
0.0–3.0
1
0
0.4
0.0–1.0
HPV33n
3
3
1.2
0.0–3.0
ND
ND
ND
HPV70
3
3
1.2
0.0–3.0
ND
ND
ND
HPV87
2
2
0.8
0.0–2.0
2
1
0.8
0.0–2.0
HPV39
2
2
0.8
0.0–2.0
1
0
0.4
0.0–1.0
HPV30
2
1
0.8
0.0–2.0
1
1
0.4
0.0–1.0
HPV54
2
2
0.8
0.0–2.0
1
0
0.4
0.0–1.0
HPV44
2
1
0.8
0.0–2.0
ND
ND
ND
HPV86
2
0
0.8
0.0–2.0
ND
ND
ND
HPV82
1
0
0.4
0.0–1.0
1
0
0.4
0.0–1.0
HPV84
1
1
0.4
0.0–1.0
1
0
0.4
0.0–1.0
HPV68
1
1
0.4
0.0–1.0
ND
ND
ND
HPV69
1
1
0.4
0.0–1.0
ND
ND
ND
HPV85
1
1
0.4
0.0–1.0
ND
ND
ND
HPV91
1
0
0.4
0.0–1.0
ND
ND
ND
HPV73
1
0
0.4
0.0–1.0
ND
ND
ND
HPV43
ND
ND
ND
1
0
0.4
0.0–1.0
ND = not detected ∗Differences in the prevalences were not significant since each pair of 95% CI overlapped. bBivalent HPV type, qquadrivalent HPV type, nnonavalent HPV type.
